摘要
目的探讨慢性阻塞性肺疾病急性加重期(AECOPD)患者选择雾化吸入布地奈德混悬液治疗后的临床效果。方法选取我院2011年1月至2013年6月AECOPD患者150例。通过随机数表法将其分为A1组(观察组75例)与A2组(对照组75例)。A2组患者选择常规治疗+甲泼尼松龙治疗;A1组患者选择常规治疗+布地奈德混悬液(雾化吸入)治疗;比较两组患者治疗7 d后在相关指标方面表现的差异性。结果两组AECOPD患者完成7 d治疗后,与治疗前比较,在动脉血氧分压(Pa O2)以及动脉血二氧化碳分压(Pa CO2)等指标差异有统计学意义(P<0.05)。结论针对AECOPD患者选择雾化吸入布地奈德混悬液治疗,表现出较高的有效性及安全性。
Objective To investigate the acute exacerbation of chronic obstructive pulmonary disease patients, clinical effect of selection of budesonide inhalation suspension method after treatment.Methods A total of 150 patients in our hospital from January 2011 to June 2013 in AECOPD patients. By random number table method will be divided into the A1 group（observation group 75 cases） and group A2（control group of 75 cases）.Group A2 patients choose the conventional treatment＋methylprednisolone treatment;group A1 patients choose the conventional treatment＋budesonide suspension（inhalation） treatment;the differences were compared between the two groups after 7 d treatment in the relevant indicators to show.Results Two AECOPD patients completed seven days after treatment were compared with those before treatment,PaO2 and Pa CO2 in other indicators,the difference was significant（P〈0.05）.Conclusion For AECOPD patients choose budesonide inhalation suspension given to clinical treatment,showed a higher effectiveness and safety.
出处
《中国药物经济学》
2015年第1期70-72,共3页
China Journal of Pharmaceutical Economics
关键词
雾化吸入
布地奈德混悬液
慢性阻塞性肺疾病
急性加重期
Atomizing inhalation
Budesonide mixed suspension
Chronic obstructive pulmonary disease
Acute exacerbation
